Fibrobiologics发布第三批Cywc628药物产品,用于1/2期糖尿病足溃疡临床试验

美股速递
Aug 27

Fibrobiologics公司宣布,已成功生产并发布第三批Cywc628药物产品,该产品将用于其正在进行的1/2期糖尿病足溃疡临床试验。这一里程碑式的进展,标志着该公司在推进这一潜在治疗方案的道路上又迈出了坚实的一步。

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10